Rafael Holdings, Inc. (RFL)Real Estate | Real Estate Services | Newark, United States | NYSE
1.49 USD
-0.03
(-1.974%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 2:24 a.m. EDT
The investment case for Rafael Holdings is currently broken by a catastrophic collapse in business fundamentals. The company is hemorrhaging cash, reporting massive operating losses of nearly 38%, and suffering a 50% contraction in revenue. The balance sheet is deteriorating with negative free cash flow and negative returns on both assets and equity. While the stock trades at a low absolute price, the valuation metrics are distorted by the lack of earnings, trading at a premium to sales that defies logic for a failing operation. The price action reflects this reality, having lost over 83% of its value over the past seven years. Although the most recent annual drop was isolated, the trajectory is clearly downward, driven by the inability to generate profit or grow top-line revenue. The recent news of a Phase 3 trial finish offers a potential catalyst, but without a proven track record of profitability or a clear path to monetization, the risk of permanent capital loss remains extreme. Options activity confirms the market's skepticism, with traders aggressively buying insurance against further declines while avoiding any exposure to upside moves. There is no dividend to provide income, and the short-term outlook is clouded by the company's operational struggles and the unreliability of statistical forecasts given the low liquidity and high volatility. This is a speculative vehicle for high-risk tolerance investors only, not a viable investment for capital preservation or steady growth. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.098865 |
| AutoARIMA | 0.101010 |
| MSTL | 0.109006 |
| AutoETS | 0.112875 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 25% |
| H-stat | 9.98 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.008 |
| Excess Kurtosis | 1.58 |
| Attribute | Value |
|---|---|
| Sector | Real Estate |
| Debt to Equity Ratio | 0.755 |
| Revenue per Share | 0.02 |
| Market Cap | 77,479,992 |
| Beta | 0.34 |
| Website | https://www.rafaelholdings.com |
As of Oct. 10, 2026, 2:24 a.m. EDT: Speculators are overwhelmingly bearish, positioning heavy protective puts (over 2,900 contracts) against virtually zero call volume. The strike distribution shows significant interest in downside protection at $2.50 and deep out-of-the-money puts at $5.00, while call buyers are absent entirely. Implied volatility is elevated on the put side relative to calls, confirming a fear-based sentiment rather than a speculative upside bet.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.08759129 |
| Address1 | 520 Broad Street |
| All Time High | 65.52268 |
| All Time Low | 1.12 |
| Ask | 1.79 |
| Ask Size | 100 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 357,370 |
| Average Daily Volume3 Month | 152,785 |
| Average Volume | 152,785 |
| Average Volume10Days | 357,370 |
| Beta | 0.344 |
| Bid | 0.0 |
| Bid Size | 1,800 |
| Board Risk | 10 |
| Book Value | 1.45 |
| City | Newark |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.49 |
| Current Ratio | 3.163 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.5685 |
| Day Low | 1.43 |
| Debt To Equity | 0.755 |
| Display Name | Rafael |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,793,190,600 |
| Earnings Timestamp Start | 1,793,190,600 |
| Ebitda | -36,238,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.463 |
| Enterprise To Revenue | 54.092 |
| Enterprise Value | 53,009,996 |
| Eps Trailing Twelve Months | -0.72 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 20 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.0046 |
| Fifty Day Average Change | -0.51460004 |
| Fifty Day Average Change Percent | -0.25670958 |
| Fifty Two Week Change Percent | 8.759129 |
| Fifty Two Week High | 3.96 |
| Fifty Two Week High Change | -2.47 |
| Fifty Two Week High Change Percent | -0.6237374 |
| Fifty Two Week Low | 1.12 |
| Fifty Two Week Low Change | 0.37 |
| Fifty Two Week Low Change Percent | 0.33035713 |
| Fifty Two Week Range | 1.12 - 3.96 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,522,157,400,000 |
| Float Shares | 31,769,918 |
| Free Cashflow | -20,674,000 |
| Full Exchange Name | NYSE |
| Full Time Employees | 21 |
| Fullday Change | -0.029999971 |
| Fullday Change Percent | -1.9736824 |
| Fullday Price | 1.49 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.95102 |
| Gross Profits | 932,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.38228 |
| Held Percent Institutions | 0.0808 |
| Implied Shares Outstanding | 51,999,996 |
| Industry | Real Estate Services |
| Industry Disp | Real Estate Services |
| Industry Key | real-estate-services |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,753,920,000 |
| Last Split Date | 1,746,748,800 |
| Last Split Factor | 1,014:1000 |
| Long Business Summary | Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 ("NPC1"), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey. |
| Long Name | Rafael Holdings, Inc. |
| Market | us_market |
| Market Cap | 77,479,992 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_542275995 |
| Most Recent Quarter | 1,777,507,200 |
| Net Income To Common | -32,553,000 |
| Next Fiscal Year End | 1,785,456,000 |
| Non Diluted Market Cap | 105,039,991 |
| Open | 1.52 |
| Operating Cashflow | -31,990,000 |
| Operating Margins | -38.37989 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 212 658 1450 |
| Pre Market Change | 0.0 |
| Pre Market Change Percent | 0.0 |
| Pre Market Price | 1.49 |
| Pre Market Time | 1,791,980,833 |
| Previous Close | 1.52 |
| Price Hint | 4 |
| Price To Book | 1.0275862 |
| Price To Sales Trailing12 Months | 79.06122 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.794 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.03 |
| Regular Market Change Percent | -1.97368 |
| Regular Market Day High | 1.5685 |
| Regular Market Day Low | 1.43 |
| Regular Market Day Range | 1.43 - 1.5685 |
| Regular Market Open | 1.52 |
| Regular Market Previous Close | 1.52 |
| Regular Market Price | 1.49 |
| Regular Market Time | 1,791,921,602 |
| Regular Market Volume | 28,036 |
| Return On Assets | -0.22766 |
| Return On Equity | -0.37595 |
| Revenue Growth | -0.506 |
| Revenue Per Share | 0.02 |
| Sand P52 Week Change | 0.17004645 |
| Sector | Real Estate |
| Sector Disp | Real Estate |
| Sector Key | real-estate |
| Share Holder Rights Risk | 9 |
| Shares Outstanding | 51,212,833 |
| Shares Percent Shares Out | 0.0152 |
| Shares Short | 789,108 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 789,900 |
| Short Name | Rafael Holdings, Inc. |
| Short Percent Of Float | 0.0365 |
| Short Ratio | 3.44 |
| Source Interval | 15 |
| State | NJ |
| Symbol | RFL |
| Total Cash | 30,497,000 |
| Total Cash Per Share | 0.586 |
| Total Debt | 610,000 |
| Total Revenue | 980,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.72 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.6783 |
| Two Hundred Day Average Change | -0.18830001 |
| Two Hundred Day Average Change Percent | -0.11219687 |
| Type Disp | Equity |
| Volume | 28,036 |
| Website | https://www.rafaelholdings.com |
| Zip | 7,102 |